Pharma Co. Seeks $2M Fee For Bid In Canceled Ch. 11 Auction
An Italian pharmaceutical company told a Delaware bankruptcy judge Tuesday that it is entitled to a $2 million fee for submitting an unsuccessful baseline bid for a bankrupt drug research firm...To view the full article, register now.
Already a subscriber? Click here to view full article